<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34403214</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1755-3768</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>100</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Acta ophthalmologica</Title>
          <ISOAbbreviation>Acta Ophthalmol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Rupture and chemical accumulation in contact lenses with dexamethasone eye drop administration after congenital cataract surgery.</ArticleTitle>
        <Pagination>
          <StartPage>462</StartPage>
          <EndPage>467</EndPage>
          <MedlinePgn>462-467</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/aos.15003</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To investigate whether contact lenses used after surgery for congenital cataracts act as a depot for dexamethasone, which would allow the prescribed amount of drops to be reduced, and to examine whether the preservative benzalkonium chloride accumulates in the contact lens matrix, which would suggest a need for more frequent replacements.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Contact lenses (n = 10) worn by infants treated with dexamethasone eye drops after congenital cataract surgery were analysed with scanning electron microscopy, UV-vis, <sup>1</sup> H-NMR and LDI-MS for chemical deposits and for changes on the contact lens surface. Unused lenses (n = 5) and lenses (n = 4) from patients with no eye drop treatment were analysed as reference.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The treated contact lenses displayed ruptured surfaces in comparison with unused and reference lenses. Dexamethasone and BAK were not detected in any of the lenses. A polyethylene oxide component was found in the treated lenses, likely originating from the dexamethasone eye drops or the contact lens solution.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Dexamethasone and BAK do not accumulate in the contact lenses, and a depot effect of any clinical significance is unlikely. Therefore, the number of drops given after surgery should remain the same regardless of whether the child has contact lenses. The ruptured surface may both decrease the child's comfort and increase the risk of microbial adhesion, and so it is recommended that contact lenses should be replaced once a month throughout the course of anti-inflammatory eye drop treatment after surgery for congenital cataract.</AbstractText>
          <CopyrightInformation>© 2021 The Authors. Acta Ophthalmologica published by John Wiley &amp; Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>De Lima</LastName>
            <ForeName>Sara</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0003-3960-9537</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Eye and Vision, Karolinska Institute, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Erdal</LastName>
            <ForeName>Nejla</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Fibre and Polymer Technology, KTH Royal Institute of Technology, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adolfsson</LastName>
            <ForeName>Karin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Fibre and Polymer Technology, KTH Royal Institute of Technology, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hakkarainen</LastName>
            <ForeName>Minna</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Fibre and Polymer Technology, KTH Royal Institute of Technology, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kugelberg</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0001-5239-6324</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Eye and Vision, Karolinska Institute, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>08</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Acta Ophthalmol</MedlineTA>
        <NlmUniqueID>101468102</NlmUniqueID>
        <ISSNLinking>1755-375X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009883">Ophthalmic Solutions</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>7S5I7G3JQL</RegistryNumber>
          <NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002386" MajorTopicYN="Y">Cataract</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003261" MajorTopicYN="Y">Contact Lenses</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007908" MajorTopicYN="Y">Lens, Crystalline</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009883" MajorTopicYN="N">Ophthalmic Solutions</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">benzalkonium chloride</Keyword>
        <Keyword MajorTopicYN="N">congenital cataract</Keyword>
        <Keyword MajorTopicYN="N">contact lenses</Keyword>
        <Keyword MajorTopicYN="N">dexamethasone</Keyword>
        <Keyword MajorTopicYN="N">paediatric cataract</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>12</Hour>
          <Minute>36</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34403214</ArticleId>
        <ArticleId IdType="doi">10.1111/aos.15003</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Babaç C, Güven G, David G, Simionescu BC &amp; Pişkin E (2004): Production of nanoparticles of methyl methacrylate and butyl methacrylate copolymers by microemulsion polymerization in the presence of maleic acid terminated poly(N-acetylethylenimine) macromonomers as cosurfactant. Eur Polym J 40: 1947-1952.</Citation>
        </Reference>
        <Reference>
          <Citation>Baradaran-Rafii A, Shirzadeh E, Eslani M &amp; Akbari M (2014): Optical correction of aphakia in children. J Ophthalmic Vis Res 9: 71-82.</Citation>
        </Reference>
        <Reference>
          <Citation>Bengani LC, Kobashi H, Ross AE et al. (2020): Steroid-eluting contact lenses for corneal and intraocular inflammation. Acta Biomater 116: 149-161.</Citation>
        </Reference>
        <Reference>
          <Citation>Birch EE, Cheng C, Stager DR Jr, Weakley DR Jr &amp; Stager DR Sr (2009): The critical period for surgical treatment of dense congenital bilateral cataracts. J AAPO 13: 67-71.</Citation>
        </Reference>
        <Reference>
          <Citation>Boone A, Hui A &amp; Jones L (2009): Uptake and release of dexamethasone phosphate from silicone hydrogel and group I, II, and IV hydrogel contact lenses. Eye Contact Lens 35: 260-267.</Citation>
        </Reference>
        <Reference>
          <Citation>Chapman JM, Cheeks L &amp; Green K (1990): Interactions of benzalkonium chloride with soft and hard contact lenses. Arch Ophthalmol 108: 244-246.</Citation>
        </Reference>
        <Reference>
          <Citation>Dumbleton K, Caffery B, Dogru M et al. (2013): The TFOS International Workshop on Contact Lens Discomfort: report of the subcommittee on epidemiology. Invest Ophthalmol Vis Sci 54: TFOS20-TFOS36.</Citation>
        </Reference>
        <Reference>
          <Citation>Erdal NB, Adolfsson KH, De Lima S &amp; Hakkarainen M (2018): In vitro and in vivo effects of ophthalmic solutions on silicone hydrogel bandage lens material Senofilcon A. Clin Exp Optom 101: 354-362.</Citation>
        </Reference>
        <Reference>
          <Citation>Giraldez MJ, Resua CG, Lira M, Oliveira ME, Magariños B, Toranzo AE &amp; Yebra-Pimentel E (2010): Contact lens hydrophobicity and roughness effects on bacterial adhesion. Optom Vis Sci 87: E426-E431.</Citation>
        </Reference>
        <Reference>
          <Citation>González-Fernández D, Torneiro M &amp; Lazzari M (2020): Some guidelines for the synthesis and melting characterization of azide poly(ethylene glycol) derivatives. Polymers (Basel) 12: 1269.</Citation>
        </Reference>
        <Reference>
          <Citation>Green M, Apel A &amp; Stapleton F (2008): Risk factors and causative organisms in microbial keratitis. Cornea 27: 22-27.</Citation>
        </Reference>
        <Reference>
          <Citation>Holden BA &amp; Mertz GW (1984): Critical oxygen levels to avoid corneal edema for daily and extended wear contact lenses. Invest Ophthalmol Vis Sci 25: 1161-1167.</Citation>
        </Reference>
        <Reference>
          <Citation>Jones L, Brennan NA, González-Méijome J et al. (2013): The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens materials, design, and care subcommittee. Invest Ophthal Vis Sci 54: TFOS37-TFOS70.</Citation>
        </Reference>
        <Reference>
          <Citation>Karlgard CC, Wong NS, Jones LW &amp; Moresoli C (2003): In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int J Pharms 257: 141-151.</Citation>
        </Reference>
        <Reference>
          <Citation>Lim ME, Buckley EG &amp; Prakalapakorn SG (2017): Update on congenital cataract surgery management. Curr Opin Ophthalmol 28: 87-92.</Citation>
        </Reference>
        <Reference>
          <Citation>Lundvall A &amp; Kugelberg U (2002a): Outcome after treatment of congenital bilateral cataract. Acta Ophthalmol Scand 80: 593-597.</Citation>
        </Reference>
        <Reference>
          <Citation>Lundvall A &amp; Kugelberg U (2002b): Outcome after treatment of congenital unilateral cataract. Acta Ophthalmol Scand 80: 588-592.</Citation>
        </Reference>
        <Reference>
          <Citation>Morgan PB, Brennan NA, Maldonado-Codina C, Quhill W, Rashid K &amp; Efron N (2010): Central and peripheral oxygen transmissibility thresholds to avoid corneal swelling during open eye soft contact lens wear. J Biomed Mater Res B Appl Biomater 92: 361-365.</Citation>
        </Reference>
        <Reference>
          <Citation>Stapleton F, Bakkar M, Carnt N et al. (2021): CLEAR - contact lens complications. Cont Lens Anterior Eye 44: 330-367.</Citation>
        </Reference>
        <Reference>
          <Citation>Sterner O, Aeschlimann R, Zürcher S, Osborn Lorenz K, Kakkassery J, Spencer ND &amp; Tosatti SG (2016): Friction measurements on contact lenses in a physiologically relevant environment: effect of testing conditions on friction. Invest Ophthal Vis Sci 57: 5383-5392.</Citation>
        </Reference>
        <Reference>
          <Citation>Sugumaran D &amp; Karim KJA (2017): Removal of copper (II) ion using chitosan-graft-poly(methyl methacrylate) as adsorbent. eProceedings. Chemistry 2: 130.</Citation>
        </Reference>
        <Reference>
          <Citation>Tang H, Cao T, Liang X, Wang A, Salley SO, McAllister J 2nd &amp; Ng KY (2009): Influence of silicone surface roughness and hydrophobicity on adhesion and colonization of Staphylococcus epidermidis. J Biomed Mater Res A 88: 454-463.</Citation>
        </Reference>
        <Reference>
          <Citation>Vaegan &amp; Taylor D (1979): Critical period for deprivation amblyopia in children. Trans Ophthalmol Soc U K 99: 432-439.</Citation>
        </Reference>
        <Reference>
          <Citation>Vidal-Rohr M, Wolffsohn JS, Davies LN &amp; Cerviño A (2018): Effect of contact lens surface properties on comfort, tear stability and ocular physiology. Cont Lens Anterior Eye 41: 117-121.</Citation>
        </Reference>
        <Reference>
          <Citation>Wiesel TN &amp; Hubel DH (1963): Effects of visual deprivation on morphology and physiology of cells in the cat’s lateral geniculate body. J Neurophysiol 26: 978-993.</Citation>
        </Reference>
        <Reference>
          <Citation>Willcox MD (2013): Microbial adhesion to silicone hydrogel lenses: a review. Eye Contact Lens 39: 61-66.</Citation>
        </Reference>
        <Reference>
          <Citation>Yavuz B &amp; Kompella UB (2017): Ocular drug delivery. Handb Exp Pharmacol 242: 57-93.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang W, Prausnitz MR &amp; Edwards A (2004): Model of transient drug diffusion across cornea. J Control Release 99: 241-258.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang X, Cao X &amp; Qi P (2020): Therapeutic contact lenses for ophthalmic drug delivery: major challenges. J Biomater Sci Polym Ed 31: 549-560.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
